a public good project by the
Synthesis
Company
of California

© 2026

R.W. Blamey | doi.page

0 works0 citations0 h-index

R.W. Blamey

Nottingham City Hospital(GB)

Publications by Year

Research Areas

Breast Cancer Treatment Studies, Estrogen and related hormone effects, Breast Lesions and Carcinomas, HER2/EGFR in Cancer Research, Global Cancer Incidence and Screening

Most-Cited Works

→ A prognostic index in primary breast cancer(1982)716 cited
→ Expression of luminal and basal cytokeratins in human breast carcinoma(2004)597 cited
→ Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up(1992)480 cited
→ Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study(2002)335 cited
→ Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up(1994)283 cited
→ Phyllodes tumours of the breast: a clinicopathological review of thirty‐two cases(1995)266 cited

→ Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma(2004)

254 cited

→ Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial(2013)220 cited

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.(1999)

→ Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999(2007)201 cited